Untitled Letter Warns Valisure About Pharmacy-Related Lapses

The FDA rapped independent testing lab Valisure in an untitled letter for violating the Drug Supply Chain Security Act (DSCSA) and for “methodological deficiencies” in its testing protocols, disputing the company’s claims that its pharmacy business was not subject to FDA regulation.
Source: Drug Industry Daily